Souhaitez-vous accéder aux communiqués récents ?

JERUSALEM, ISRAEL--(Marketwired - March 16, 2016) - LeukoDx, an emerging leader in the field of fully-automated cell-based assays, and GE Healthcare's Life Sciences business, a provider of...

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Sep 13, 2015) - LeukoDx, developers of a compact device for diagnosing life-threatening sepsis, is joining doctors, hospitals, healthcare systems,...

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Apr 27, 2015) - Red Herring announced its Red Herring Europe award winners, recognizing Europe's leading private companies and celebrating these...

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Apr 21, 2015) - LeukoDx Inc., an emerging leader in the field of innovative medical diagnostic technology, announced today the appointment of Dr....

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Mar 24, 2015) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, announced today that it has been selected as a Finalist...

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Jan 27, 2015) - LeukoDx Inc., an emerging leader in the field of innovative medical diagnostic technology, today announced that it has completed all...

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Sep 30, 2014) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced the appointment of Ephraim Carlebach,...

TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Jun 16, 2014) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced that it has secured $7 million in new...

TOWSON, MD and JERUSALEM--(Marketwire - Nov 8, 2012) - LeukoDx Inc. is pleased to announce it has reached a significant milestone by completing the development of a functional alpha prototype of...

JERUSALEM--(Marketwire - May 15, 2012) - LeukoDx Ltd. is pleased to announce that it has secured approval for a grant from the Office of the Chief Scientist in Israel for the third year. The...